A. E. Wakeling
Impact in
Papers in
- Co-authors
- Jean Bowler (9 shared papers)Michael Dukes (3 shared papers)Robert I. Nicholson (18 shared papers)Rachel Schiff (2 shared papers)Jianzhong Shou (1 shared paper)Suleiman Massarweh (2 shared papers)Helen A. Weiss (1 shared paper)C. K. Osborne (1 shared paper)
- Journals
- Endocrine Related Cancer (8 papers)Journal of Endocrinology (6 papers)European Journal of Cancer (4 papers)JNCI Journal of the National Cancer Institute (4 papers)Annals of the New York Academy of Sciences (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
A. E. Wakeling
76 papers receiving 6.9k citations
A. E. Wakeling's Hit Papers
Peers
Comparison fields: 5 of 125
- Genetics 3.6k
- Oncology 2.6k
- Cancer Research 871
- Toxicology 204
- Endocrinology, Diabetes and Metabolism 732
Countries citing papers authored by A. E. Wakeling
This map shows the geographic impact of A. E. Wakeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Wakeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Wakeling more than expected).
Fields of papers citing papers by A. E. Wakeling
This network shows the impact of papers produced by A. E. Wakeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Wakeling. The network helps show where A. E. Wakeling may publish in the future.
Co-authors
The 25 scholars most cited alongside A. E. Wakeling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. Hit paper breakdown → | 1993 | 1031 |
| 2 | A potent specific pure antiestrogen with clinical potential. Hit paper breakdown → | 1991 | 990 |
| 3 | Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer Hit paper breakdown → | 2004 | 951 |
| 4 | 2004 | 317 | |
| 5 | 1995 | 309 | |
| 6 | 1987 | 275 | |
| 7 | 2004 | 257 | |
| 8 | 1988 | 192 | |
| 9 | Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. | 2001 | 190 |
| 10 | 2000 | 163 | |
| 11 | 1996 | 144 | |
| 12 | 2003 | 143 | |
| 13 | 2001 | 137 | |
| 14 | 1988 | 136 | |
| 15 | 1988 | 126 | |
| 16 | 1993 | 99 | |
| 17 | 1989 | 97 | |
| 18 | 1984 | 97 | |
| 19 | Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. | 1989 | 88 |
| 20 | Pharmacology and clinical uses of inhibitors of hormone secretion and action | 1987 | 80 |
About A. E. Wakeling
A. E. Wakeling is a scholar working on Genetics, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 77 papers that have together received 7.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (53 papers), HER2/EGFR in Cancer Research (20 papers), Phytoestrogen effects and research (9 papers), Effects and risks of endocrine disrupting chemicals (6 papers), Steroid Chemistry and Biochemistry (5 papers), Cancer Treatment and Pharmacology (5 papers), Hormonal and reproductive studies (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Genetics (3.6k citations), Oncology (2.6k citations), Cancer Research (871 citations), Toxicology (204 citations) and Endocrinology, Diabetes and Metabolism (732 citations). A. E. Wakeling has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jean Bowler, Michael Dukes, Robert I. Nicholson, Rachel Schiff, Jianzhong Shou, Suleiman Massarweh, Helen A. Weiss, C. K. Osborne, Simak Ali and M. Sikorska. Their work appears in journals such as Endocrine Related Cancer, Journal of Endocrinology, European Journal of Cancer, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.